Eubulus-A80

CAS No. 2703776-20-7

Eubulus-A80( —— )

Catalog No. M35360 CAS No. 2703776-20-7

Eubulus-A80 is a anti-tumor agent (WO2021/183702, Compound A80).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 426 Get Quote
50MG 1270 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Eubulus-A80
  • Note
    Research use only, not for human use.
  • Brief Description
    Eubulus-A80 is a anti-tumor agent (WO2021/183702, Compound A80).
  • Description
    GPX4-IN-8 (compound A80) is a potent GPX4 inhibitor. GPX4-IN-8 shows antiproliferative activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2703776-20-7
  • Formula Weight
    396.87
  • Molecular Formula
    C22H21ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C(C#C)=O)(C1(C(NCC2=CC=CC=C2)=O)CCOCC1)C3=CC(Cl)=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sheldon Cao, et al. Gpx4 inhibitors, pharmaceutical compositions thereof, and their use for treating gpx4-mediated diseases. WO2021183702A1.
molnova catalog
related products
  • Kinase Domain of Ins...

    Kinase Domain of Insulin Receptor (5)

  • (±)-Lisofylline

    (±)-Lisofylline is an enantiomer-specific, alkyl-substituted methylxanthine, which has specific and potent activity in down-regulating leukocyte activation. (±)-Lisofylline is an anti-inflammatory agent.

  • PK68

    PK68 is an effective and selective inhibitor of type II receptor-interacting kinase 1 (RIPK1, IC50 = 90?nM). PK68 can be used for research on the treatment of inflammatory disorders and cancer metastasis.